Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)
Condition(s):Asthma With Allergic RhinitisLast Updated:February 6, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Asthma With Allergic RhinitisLast Updated:February 6, 2024Recruiting
Condition(s):Older Age; DepressionLast Updated:January 3, 2024Recruiting
Condition(s):Lifestyle, Healthy; Pregnancy Related; Adherence, Treatment; Nutrition, Healthy; Weight Gain, MaternalLast Updated:March 5, 2024Recruiting
Condition(s):Oxygen Consumption; Mitochondria; Blood Flow; Aerobic CapacityLast Updated:January 2, 2024Completed
Condition(s):Diet, HealthyLast Updated:January 5, 2024Recruiting
Condition(s):Breast CancerLast Updated:December 29, 2023Not yet recruiting
Condition(s):Myotonic Dystrophy Type 1 (DM1)Last Updated:March 21, 2024Recruiting
Condition(s):Juvenile Idiopathic ArthritisLast Updated:December 28, 2023Recruiting
Condition(s):Dental Anxiety; Dental Phobia; Dental Trauma; Dental DiseasesLast Updated:December 27, 2023Recruiting
Condition(s):Anxiety; Milk Expression, Breast; Breast Milk CollectionLast Updated:December 27, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.